Jul 21, 2026, 13:05
Danai Poutakidou։ The Diagnostic Pitfalls of Unexpected PT/INR Prolongation
Danai Poutakidou, Member (Alternate) of the Accreditation Commission for Medical Specialists in Clinical Biology, Head of Hematology Department at Brussels University Hospital Laboratory LHUB-ULB, shared a post on LinkedIn:
“Delighted to showcase the work of our LHUB‑ULB hemostasis team at ISTH2026.
This case underlines how expert analytical review and proper reagent selection help uncover a Lupus Anticoagulant behind an unexpected PT/INR prolongation, avoiding major diagnostic pitfalls.
Grateful to our hemostasis experts Kleio Ouzounelli and Mirvate Harb for their key contributions to this challenging and insightful investigation.”
Stay updated with Hemostasis Today.
-
Sep 2, 2026, 18:26Strengthening Comprehensive Care for Inherited Bleeding Disorders in Ecuador – World Federation of Hemophilia
-
Sep 2, 2026, 18:24Zeeshan Ahmed Khattak: Managing Febrile Neutropenia in Hematology/Oncology and Transplant Patients
-
Sep 2, 2026, 18:22Mark Heyland: The Role of Thromboinflammation in Fracture Non-Union
-
Sep 2, 2026, 18:18Katie Gonzalez: Understanding the Hidden Risk of Inherited Thrombophilias
-
Sep 2, 2026, 18:14Beruni Narmada W: Rare Basal Vein of Rosenthal Thrombosis Presenting With Thalamic Haemorrhage
-
Sep 2, 2026, 18:03Omnia Ahmed: Effect of Hematocrit (HCT) on Coagulation Testing
-
Sep 2, 2026, 17:44John Thymis: Five E-Posters Presented at ESC Congress 2026 in Munich
-
Sep 2, 2026, 17:42Edward Lee Carter: In Antithrombotic Therapy, “More Protection” Can Become More Harm Surprisingly Quickly
-
Sep 2, 2026, 17:41Mohsin Raza: Why Is Anticoagulation Used During Hemodialysis?